Eyedrops Tainted With Printer’s Ink – Bausch and Lomb Recall
Bausch and Lomb is recalling 35,800 eye drops because black particles have been identified in some packs.
The company has sent letters to doctors and chemists ordering the return of the products to their New York base.
Initial investigations suggest that the contaminant is printing ink, in which case we understand that the risk of toxicity is low.
‘No other batches of this or any other product are affected.
‘Healthcare Professionals are asked to quarantine remaining stock and contact the wholesaler from which it was obtained to arrange uplift and replacement.’
A spokeswoman said: ‘Bausch and Lomb is conducting a voluntary recall of a single lot of proxymetacaine 0.5% Minims Eye Drops Solution.
‘We chose to initiate this recall after confirming a report of the presence of foreign particles in a product from this single lot.
‘No adverse events have been reported which have been attributed to the defective product in this single lot. No other lots have been affected.
‘No other products in the Minims range or other Bausch and Lomb products are affected by this action.
‘We are working closely with the MHRA to provide updated information regarding this recall action.’
An MHRA spokesperson added: There is no evidence that any patients are experiencing any problems from these eye drops and testing has shown that there is a low risk of any patients having any adverse reactions.